RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study.
Olivier LucidarmeMathilde WagnerPaul GillardStefano KimJean-Baptiste BachetBenoit RousseauThibault MazardChristophe LouvetBenoist ChibaudelRomain CohenMarie-Line Garcia-LarnicolAurelien GobertJulie HenriquesThierry AndréPublished in: Cancer imaging : the official publication of the International Cancer Imaging Society (2019)
ClinicalTrials.gov Identifier: NCT02699073.Registered March 4, 2016, Retrospectively registered.
Keyphrases